# First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C

> **NCT02510248** · PHASE1 · TERMINATED · sponsor: **Alios Biopharma Inc.** · enrollment: 42 (actual)

## Conditions studied

- Chronic Hepatitits C

## Interventions

- **DRUG:** AL-704
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02510248
- **Lead sponsor:** Alios Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-31
- **Primary completion:** 2015-11-24
- **Final completion:** 2015-11-24
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02510248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02510248, "First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02510248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*